2m 2m 2m 2m 2m 2m 2m
INMED PHARMA (INM)
NASDAQ
$1.54+$0.02 (+1.58%)
Price as of Jun 03, 2026 6:16 PM EDT- $5.2MMarket Cap
- -54.22%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
INMED PHARMA (INM)
$1.54+$0.02 (+1.58%)
INM | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.52 | ||
Change | -$0.04 (-2.56%) | ||
Open | $1.55 | ||
High | $1.56 | ||
Low | $1.49 | ||
Previous Close | $1.56 | ||
Volume | 156,949 | ||
30-Day Average Volume | 4,797,633 | ||
1-Week Change | -11.63% | ||
1-Month Change | 112.74% | ||
1-Year Change | -54.22% | ||
3-Year Change | -94.06% | ||
5-Year Change | -99.90% | ||
Fundamentals | |||
Shares Outstanding | 3.3M | ||
Total Assets | $9.1M | ||
Market Cap | $5.2M | ||
Enterprise Value | $44,146.00 | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$3.0M | ||
Free Cash Flow | -$1.7M | ||
EBIT | -$3.0M | ||
EBITDA | -$2.9M | ||
Net Working Capital | $4.7M | ||
EPS | -$0.73 | ||
Enterprise Value/EBITDA | -0 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 1 | ||
P/E | -2 | ||
PEG | 0 | ||
Price/Free Cash Flow | -3 | ||
Price/Operating Cash Flow | -3 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 20 | ||
Last Split Date | 11/14/2024 | ||
Earnings & Revenue